Mother Jones: Can an Oversight Board Created by Facebook Actually Fix the Company’s Failings?
March 19, 2021 — Mother Jones turned to Economic Liberties’ Steering Committee Member Zephyr Teachout to understand the failings of the Facebook Oversight Board.
Financial Times: Pharma is riding a vaccine high, but reputational risks loom
March 17, 2021 — The Financial Times reached out to Economic Liberties’ Policy Analyst Olivia Webb spoke to discuss Big Pharma and whether recent positive PR will shield the industry from campaigns like Investigate Insulin Now.
New Yorker: A Kansas Bookshop’s Fight with Amazon Is About More Than the Price of Books
March 12, 2021 — In a must-read feature that noted the influence of Research Director Matt Stoller’s book Goliath, The New Yorker illustrated how Amazon’s monopoly power is crushing independent bookstores across the country — and every other independent business that defines American downtowns.
Politico Morning Tech: Facebook, Google brace for antitrust double-header in Congress
March 11, 2021 — In an exclusive feature, Politico’s Morning Tech covered Economic Liberties’ new database, which finds that 80% of corporations worth more than $100 billion have faced antitrust scrutiny.
Politico Pulse: The deadliest year in U.S. history
March 11, 2021 — Politico Pulse dove into Investigate Insulin Now, a new campaign Economic Liberties launched with 43 organizational partners and patient advocates to demand the Federal Trade Commission investigate and prosecute this deadly pharmaceutical cartel.